Lenalidomide enhances anti-myeloma cellular immunityKatarina Luptakova, David Avigan, James D. Levine et al.|Cancer Immunology Immunotherapy|2012Cited by 161
MUC1 Is a Potential Target for the Treatment of Acute Myeloid Leukemia Stem CellsDina Stroopinsky, David Avigan, Jacalyn Rosenblatt et al.|Cancer Research|2013Cited by 54
Targeting Acute Myeloid Leukemia Stem Cells by MUC1-C Subunit InhibitionDina Stroopinsky, David Avigan, Jacalyn Rosenblatt et al.|Blood|2010Cited by 2
MUC1 Expression Is Essential For Establishment Of Acute Myeloid Leukemia In VivoDina Stroopinsky, David Avigan, Hasan Rajabi et al.|Blood|2013Cited by 0
Supplementary Figure 2 from MUC1 Is a Potential Target for the Treatment of Acute Myeloid Leukemia Stem CellsDina Stroopinsky, David Avigan, Jacalyn Rosenblatt et al.|Unknown|2023Cited by 0